About the coverage
From years of research to bringing a product to market, building a health technology company takes persistence. In this December 2023 feature, Forbes contributor Geri Stengel profiles Sigrid Therapeutics and its cofounders, Sana Alajmovic and Tore Bengtsson.
The article explores Alajmovic’s personal motivation, Bengtsson’s research into engineered silica and the challenges of securing investment. It also covers the company’s US launch of Glucose Stabilizer in November 2023, offering a snapshot of an important stage in its development.
In the article
- The founders’ backgrounds and motivation
- The research and development journey behind SiPore®
- Raising capital and bringing the first product to market
